SHOC2 Leucine Rich Repeat Scaffold Protein (SHOC2), encoded by the SHOC2 gene in humans, is a critical component of the RAS-MAPK signaling pathway. This signaling pathway is important in cell proliferation, differentiation, and survival.SHOC2 functions as a scaffold protein, a type of protein that does not directly catalyze reactions but instead facilitates signal transduction by bringing together other proteins into complexes. Specifically, SHOC2 promotes the dephosphorylation and activation of RAF proteins, which are key players in the RAS-MAPK pathway.
The protein contains several leucine-rich repeats (LRRs), structural motifs often involved in protein-protein interactions. These repeats enable SHOC2 to interact with various proteins within the RAS-MAPK pathway, facilitating signal transduction.Mutations in the SHOC2 gene can lead to an increased activity of the RAS-MAPK pathway. A specific mutation, leading to a S2G change in SHOC2, has been associated with a condition called Noonan-like syndrome with loose anagen hair, characterized by features such as distinctive facial features, short stature, heart defects, and developmental delay. This mutation disrupts the normal localization of SHOC2 within the cell, enhancing RAS-MAPK signaling.In summary, SHOC2 is a scaffold protein involved in the RAS-MAPK signaling pathway. It facilitates signal transduction by bringing together various proteins into functional complexes. Mutations in SHOC2 can lead to hyperactivation of the RAS-MAPK pathway, contributing to conditions such as Noonan-like syndrome with loose anagen hair.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
MEK inhibitors can indirectly influence SHOC2 function by modulating the ERK/MAPK pathway, which SHOC2 helps regulate. | ||||||
SCH772984 | 942183-80-4 | sc-473205 | 5 mg | $370.00 | 5 | |
By inhibiting ERK, these compounds can affect downstream signaling of the RAS-MAPK pathway, potentially impacting SHOC2 function. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
RAF inhibitors can affect the upstream signaling of the RAS-MAPK pathway, potentially altering SHOC2-mediated processes. | ||||||
Tipifarnib | 192185-72-1 | sc-364637 | 10 mg | $720.00 | ||
These inhibitors affect the post-translational modification of RAS, potentially influencing SHOC2's role in RAS-MAPK signaling. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitors may indirectly affect SHOC2 function by altering protein degradation pathways. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Tyrosine kinase inhibitors can affect various signaling pathways, potentially influencing SHOC2's role in cell signaling. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
These inhibitors can change gene expression patterns, possibly affecting SHOC2 expression. | ||||||
L-Tryptophan | 73-22-3 | sc-280888 sc-280888A sc-280888B | 100 g 1 kg 5 kg | $129.00 $364.00 $1795.00 | ||
Wnt pathway activators may indirectly modulate SHOC2 function by influencing its expression during cellular signaling. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
HSP90 inhibitors can disrupt protein folding and function, potentially affecting proteins involved in signaling pathways like SHOC2. | ||||||